Inhibitory Effect of Lomerizine, a Diphenylpiperazine Ca2+-Channel Blocker, on Ba2+ Current through Voltage-Gated Ca2+ Channels in PC12 Cells.
-
- Watano Tomokazu
- Department of Pharmacology, New Drug Discovery Research Laboratory, Kanebo Ltd.
-
- Hara Hideaki
- Department of Pharmacology, New Drug R & D Laboratory, Kanebo Ltd.
-
- Sukamoto Takayuki
- Department of Pharmacology, New Drug R & D Laboratory, Kanebo Ltd.
書誌事項
- タイトル別名
-
- Inhibitory Effect of Lomerizine a Diphe
この論文をさがす
抄録
We investigated the effect of lomerizine, an anti-migraine drug, on the Ba2+ current through voltage-gated Ca2+ channels in rat pheochromocytoma (PC12) cells using a whole-cell voltage-clamp technique. Lomerizine inhibited the Ba2+ current with an IC50 value of 1.9 μM. Lomerizine and nicardipine were > 4 times more potent than flunarizine, diltiazem, verapamil and dimetotiazine. The time course of inactivation induced by lomerizine was similar to that induced by nicardipine and flunarizine. These data indicate that lomerizine may inhibit the Ca2+ channel in a similar manner to nicardipine and flunarizine, and its potency is almost equal to that of nicardipine.
収録刊行物
-
- Jpn.J.Pharmacol.
-
Jpn.J.Pharmacol. 75 (2), 209-213, 1997
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204285271552
-
- NII論文ID
- 10008189800
-
- NII書誌ID
- AA00691188
-
- COI
- 1:CAS:528:DyaK2sXntVKmu78%3D
-
- ISSN
- 13473506
- 00215198
- http://id.crossref.org/issn/00215198
-
- NDL書誌ID
- 4326422
-
- PubMed
- 9414039
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可